Leila Alland - 02 Feb 2026 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role: Director
Signature: /s/ Leila Alland
Issuer symbol: ABEO
Transactions as of: 02 Feb 2026
Net transactions value: -$91,962
Form type: 4
Filing time: 02 Feb 2026, 16:30:02 UTC
Previous filing: 27 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Alland Leila	Director	6555 CARNEGIE AVE., 4TH FLOOR, CLEVELAND	/s/ Leila Alland	02 Feb 2026	0001825216

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABEO	Common Stock	Sale	$91,962	-18,065	-9.4%	$5.09	173,614	02 Feb 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Content

The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.